LONDON, Nov. 11, 2025 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant ownership stake in Toyota Industries Corporation (“Toyota Industries” or the “Company”), making Elliott one of the Company’s largest shareholders, today issued the following statement:
Elliott confirms that it has a significant investment in Toyota Industries and that it has been sharing its views with the Company’s management team, Board and other constituents regarding the proposed transaction with Toyota Fudosan. Elliott believes the proposed transaction very significantly undervalues Toyota Industries and reflects a process that has lacked transparency and has fallen short of proper governance practices.
About Elliott
Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.
Media Contacts:
London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk
New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com
Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp
Logo – https://mma.prnewswire.com/media/2705826/5613572/Elliott_WhiteText_Green_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/elliott-statement-on-toyota-industries-corporation-302611252.html
MUMBAI, India, Dec. 6, 2025 /PRNewswire/ -- Godrej Industries Group recently hosted its inaugural Assistive…
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab…
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results selected as one…
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L preliminary systemic activity…
- France becomes Seegene's eighth overseas sales subsidiary and third in Europe, following Italy and Germany-…
Company Set to Play a Key Role in Strengthening India's Custom Silicon CapabilitiesHYDERABAD, India, Dec.…